The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Settmacher, B.
Right arrow Articles by Klos, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Settmacher, B.
Right arrow Articles by Klos, A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*12-O-TETRADECANOYLPHORBOL-13-ACETATE
The Journal of Immunology, 1999, 162: 7409-7416.
Copyright © 1999 by The American Association of Immunologists

Modulation of C3a Activity: Internalization of the Human C3a Receptor and its Inhibition by C5a1

Britta Settmacher, Daniel Bock, Henry Saad, Sören Gärtner, Claudia Rheinheimer, Jörg Köhl, Wilfried Bautsch and Andreas Klos2

Institute of Medical Microbiology, Hannover Medical School, Hannover, Germany

The C3a receptor (C3aR) is expressed on most human peripheral blood leukocytes with the exception of resting lymphocytes, implying a much higher pathophysiological relevance of the anaphylatoxin C3a as a proinflammatory mediator than previously thought. The response to this complement split product must be tightly regulated in situations with sustained complement activation to avoid deleterious effects caused by overactivated inflammatory cells. Receptor internalization, an important control mechanism described for G protein-coupled receptors, was investigated. Using rabbit polyclonal anti-serum directed against the C3aR second extracellular loop, a flow cytometry-based receptor internalization assay was developed. Within minutes of C3a addition to human granulocytes, C3aR almost completely disappeared from the cell surface. C3aR internalization could also be induced by PMA, an activator of protein kinase C. Similarly, monocytes, the human mast cell line HMC-1, and differentiated monocyte/macrophage-like U937-cells exhibited rapid agonist-dependent receptor internalization. Neither C5a nor FMLP stimulated any cross-internalization of the C3aR. On the contrary, costimulation of granulocytes with C5a, but not FMLP, drastically decreased C3aR internalization. This effect could be blocked by a C5aR-neutralizing mAb. HEK293-cells transfected with the C3aR, with or without G{alpha}16, a pertussis toxin-resistant G protein {alpha} subunit required for C3aR signal transduction in these cells, did not exhibit agonist-dependent C3aR internalization. Additionally, preincubation with pertussis toxin had no effect on C3a-induced internalization on PMNs. C3aR internalization is a rapid negative control mechanism and is influenced by the C5aR pathway.




This article has been cited by other articles:


Home page
J. Immunol.Home page
X. Zhang, I. P. Lewkowich, G. Kohl, J. R. Clark, M. Wills-Karp, and J. Kohl
A Protective Role for C5a in the Development of Allergic Asthma Associated with Altered Levels of B7-H1 and B7-DC on Plasmacytoid Dendritic Cells
J. Immunol., April 15, 2009; 182(8): 5123 - 5130.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. U. Schraufstatter, R. G. DiScipio, M. Zhao, and S. K. Khaldoyanidi
C3a and C5a Are Chemotactic Factors for Human Mesenchymal Stem Cells, Which Cause Prolonged ERK1/2 Phosphorylation
J. Immunol., March 15, 2009; 182(6): 3827 - 3836.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. A. Melendi, S. J. Hoffman, R. A. Karron, P. M. Irusta, F. R. Laham, A. Humbles, B. Schofield, C.-H. Pan, R. Rabold, B. Thumar, et al.
C5 Modulates Airway Hyperreactivity and Pulmonary Eosinophilia during Enhanced Respiratory Syncytial Virus Disease by Decreasing C3a Receptor Expression
J. Virol., January 15, 2007; 81(2): 991 - 999.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Purwar, M. Wittmann, J. Zwirner, M. Oppermann, M. Kracht, O. Dittrich-Breiholz, R. Gutzmer, and T. Werfel
Induction of C3 and CCL2 by C3a in Keratinocytes: A Novel Autocrine Amplification Loop of Inflammatory Skin Reactions
J. Immunol., October 1, 2006; 177(7): 4444 - 4450.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Schaefer, S. Konrad, J. Thalmann, C. Rheinheimer, K. Johswich, B. Sohns, and A. Klos
The Transcription Factors AP-1 and Ets Are Regulators of C3a Receptor Expression
J. Biol. Chem., December 23, 2005; 280(51): 42113 - 42123.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Boos, I. L. Campbell, R. Ames, R. A. Wetsel, and S. R. Barnum
Deletion of the Complement Anaphylatoxin C3a Receptor Attenuates, Whereas Ectopic Expression of C3a in the Brain Exacerbates, Experimental Autoimmune Encephalomyelitis
J. Immunol., October 1, 2004; 173(7): 4708 - 4714.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Soruri, Z. Kiafard, C. Dettmer, J. Riggert, J. Kohl, and J. Zwirner
IL-4 Down-Regulates Anaphylatoxin Receptors in Monocytes and Dendritic Cells and Impairs Anaphylatoxin-Induced Migration In Vivo
J. Immunol., March 15, 2003; 170(6): 3306 - 3314.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. S. Ames, D. Lee, J. J. Foley, A. J. Jurewicz, M. A. Tornetta, W. Bautsch, B. Settmacher, A. Klos, K. F. Erhard, R. D. Cousins, et al.
Identification of a Selective Nonpeptide Antagonist of the Anaphylatoxin C3a Receptor That Demonstrates Antiinflammatory Activity in Animal Models
J. Immunol., May 15, 2001; 166(10): 6341 - 6348.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Werfel, K. Kirchhoff, M. Wittmann, G. Begemann, A. Kapp, F. Heidenreich, O. Gotze, and J. Zwirner
Activated Human T Lymphocytes Express a Functional C3a Receptor
J. Immunol., December 1, 2000; 165(11): 6599 - 6605.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.